Related references
Note: Only part of the references are listed.Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
Silvia Lanfranconi et al.
TRIALS (2020)
Transcriptome analysis provides new molecular signatures in sporadic Cerebral Cavernous Malformation endothelial cells
Concetta Scimone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Could propranolol be beneficial in adult cerebral cavernous malformations?
Caroline Apra et al.
NEUROSURGICAL REVIEW (2019)
Cranial Cavernous Malformations Natural History and Treatment
Christopher J. Stapleton et al.
STROKE (2018)
A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion
Grazia Nardella et al.
HUMAN MUTATION (2018)
Two Novel KRIT1 and CCM2 Mutations in Patients Affected by Cerebral Cavernous Malformations: New Information on CCM2 Penetrance
Concetta Scimone et al.
FRONTIERS IN NEUROLOGY (2018)
Review of familial cerebral cavernous malformations and report of seven additional families
Ivo J. H. M. de Vos et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data
Margaret A. Horne et al.
LANCET NEUROLOGY (2016)
Management of Cerebral Cavernous Malformations: From Diagnosis to Treatment
Nikolaos Mouchtouris et al.
TheScientificWorldJOURNAL (2015)
Management of Cerebral Cavernous Malformations: From Diagnosis to Treatment
Nikolaos Mouchtouris et al.
Scientific World Journal (2015)
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis
David A. McDonald et al.
HUMAN MOLECULAR GENETICS (2014)
Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort
S. Arthur Moore et al.
JOURNAL OF NEUROSURGERY (2014)
PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations
Maria Sole Cigoli et al.
PLOS ONE (2014)
High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors
Stefanie Spiegler et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2014)
Patterns and Mutational Signatures of Tandem Base Substitutions Causing Human Inherited Disease
Jian-Min Chen et al.
HUMAN MUTATION (2013)
Cutaneous Venous Malformations Related to KRIT1 Mutation: Case Report and Literature Review
Francesca Romana Grippaudo et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study
Rustam Al-Shahi Salman et al.
LANCET NEUROLOGY (2012)
Prospective hemorrhage risk of intracerebral cavernous malformations
K. D. Flemming et al.
NEUROLOGY (2012)
Cavernous malformations of the central nervous system combined with cutaneous vascular lesions due to KRIT1 mutation: A case report
Min-Yu Lan et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation
Chad W. Washington et al.
NEUROSURGICAL FOCUS (2010)
Cutaneous Venous Malformations in Familial Cerebral Cavernomatosis Caused by KRIT1 Gene Mutations
Agusti Toll et al.
DERMATOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
Axel Pagenstecher et al.
HUMAN MOLECULAR GENETICS (2009)
Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations
J. Sirvente et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Genetics of cavernous angiomas
Pierre Labouge et al.
LANCET NEUROLOGY (2007)
Genotype-phenotype correlations in cerebral cavernous malformations patients
Christian Denier et al.
ANNALS OF NEUROLOGY (2006)
Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation
FG Lehnhardt et al.
ARCHIVES OF NEUROLOGY (2005)
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations
F Bergametti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations
CL Liquori et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
